C3 STAR Trial

Dear C3 Community,   We’re excited to share updates on the C3-led clinical trial, “ STAR-BD01” , which will use Tumor Infiltrating Lymphocytes (TIL) therapy to treat biliary tract cancers. We know this trial represents hope for many, and we’re committed to keeping you informed about our progress, challenges, and next steps.   TIL therapy is a form of personalized cell therapy that has shown promising results across various cancer types, including cholangiocarcinoma. Currently